NO20045065L - Nytt formatsalt av o-desmetyl-venlafaxin - Google Patents
Nytt formatsalt av o-desmetyl-venlafaxinInfo
- Publication number
- NO20045065L NO20045065L NO20045065A NO20045065A NO20045065L NO 20045065 L NO20045065 L NO 20045065L NO 20045065 A NO20045065 A NO 20045065A NO 20045065 A NO20045065 A NO 20045065A NO 20045065 L NO20045065 L NO 20045065L
- Authority
- NO
- Norway
- Prior art keywords
- desmethyl
- venlafaxine
- new format
- format salt
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Det beskrives et nytt salt av 0-desmetyl-venlafaxin, 0-desmetyl-venlafaxinformiat. Farmasøytiske blandinger, doseringsformer og bruksmåter beskrives også.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38732102P | 2002-06-10 | 2002-06-10 | |
PCT/US2003/018195 WO2003103603A2 (en) | 2002-06-10 | 2003-06-09 | Novel formate salt of o-desmethyl-venlafaxine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045065L true NO20045065L (no) | 2005-01-07 |
Family
ID=29736291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045065A NO20045065L (no) | 2002-06-10 | 2004-11-22 | Nytt formatsalt av o-desmetyl-venlafaxin |
Country Status (20)
Country | Link |
---|---|
US (2) | US7001920B2 (no) |
EP (1) | EP1519720A4 (no) |
JP (1) | JP4445853B2 (no) |
KR (1) | KR20050013125A (no) |
CN (1) | CN1658861A (no) |
AR (1) | AR040177A1 (no) |
AU (1) | AU2003247515A1 (no) |
BR (1) | BR0311693A (no) |
CA (1) | CA2488613A1 (no) |
CR (1) | CR7583A (no) |
EC (1) | ECSP045491A (no) |
IL (1) | IL165584A0 (no) |
MX (1) | MXPA04012347A (no) |
NO (1) | NO20045065L (no) |
NZ (1) | NZ537142A (no) |
RU (1) | RU2004139075A (no) |
TW (1) | TW200407108A (no) |
UA (1) | UA84271C2 (no) |
WO (1) | WO2003103603A2 (no) |
ZA (1) | ZA200409981B (no) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7579160B2 (en) * | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US6342533B1 (en) | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
CA2368083A1 (en) * | 1999-04-06 | 2000-10-12 | Sepracor Inc. | Derivatives of venlafaxine and methods of preparing and using the same |
CA2436668C (en) | 2001-02-12 | 2009-05-26 | Wyeth | Novel succinate salt of o-desmethyl-venlafaxine |
TW200402289A (en) * | 2002-05-17 | 2004-02-16 | Wyeth Corp | Methods of treating gastrointestinary and genitourinary pain disorders |
US8679533B2 (en) | 2002-07-25 | 2014-03-25 | Pharmacia Corporation | Pramipexole once-daily dosage form |
EP1523981A1 (en) * | 2003-10-13 | 2005-04-20 | Wyeth | Extended release formulations of venlafaxine |
AU2005212166A1 (en) * | 2004-02-06 | 2005-08-25 | Wyeth | Multiparticulate O-desmethylvenlafaxine salts and uses thereof |
MX2007001706A (es) * | 2004-08-13 | 2007-04-12 | Boehringer Ingelheim Int | Formulacion de comprimidos de liberacion extendida que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para su fabricacion y su uso. |
AU2006265008A1 (en) * | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and O-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
GT200600396A (es) * | 2005-09-07 | 2007-04-23 | Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales | |
GT200600397A (es) * | 2005-09-07 | 2007-08-28 | Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales | |
WO2009027766A2 (en) * | 2006-12-22 | 2009-03-05 | Medichem, S.A. | New crystalline solid forms of o-desvenlafaxine base |
AU2008218997B2 (en) * | 2007-02-21 | 2013-06-20 | Sunovion Pharmaceuticals Inc. | Solid forms comprising (-) O-desmethylvenlafaxine and uses thereof |
BRPI0812501A2 (pt) * | 2007-07-12 | 2015-06-16 | Reddys Lab Ltd Dr | O-desmetil venlafaxina |
US20090076162A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched desvenlafaxine |
CA2702664A1 (en) * | 2007-10-16 | 2009-04-23 | Alphapharm Pty Ltd | Controlled-release pharmaceutical formulation |
EP2212275A2 (en) * | 2007-10-22 | 2010-08-04 | Actavis Group PTC EHF | Solid forms of (±)-o-desmethylvenlafaxine salts |
CA2703647A1 (en) * | 2007-10-26 | 2009-04-30 | Generics [Uk] Limited | Process for preparing o-desmethylvenlafaxine |
EP2085377A1 (en) * | 2008-01-29 | 2009-08-05 | LEK Pharmaceuticals D.D. | Novel salts of O-desmethyl-venlafaxine |
EP2262758A4 (en) * | 2008-03-12 | 2011-12-07 | Reddys Lab Ltd Dr | O-desmethylvenlafaxine SALTS |
IN2008CH00818A (no) * | 2008-04-01 | 2009-10-09 | Actavis Group Ptc Ehf | |
EP2119695A1 (en) | 2008-05-16 | 2009-11-18 | Krka | Preparation of O-desmethylvenlafaxine salts |
EP2119696A1 (en) | 2008-05-16 | 2009-11-18 | Krka | Preparation of O-desmethylvenlafaxine salts |
WO2009155488A2 (en) * | 2008-06-19 | 2009-12-23 | Segrub, Llc | Novel oxalate salt and crystal of o-desmethylvenlafaxine |
KR101022335B1 (ko) * | 2008-08-01 | 2011-03-22 | 제일약품주식회사 | 신규4-(2-(디메틸아미노)-1-(1-하이드록시사이클로헥실)에틸)페녹시 유도체 또는 이의 약학적으로 허용가능한 염, 이의제조방법 및 이를 유효성분으로 함유하는 중추신경계 질환예방 및 치료용 조성물 |
CN101716168B (zh) * | 2008-10-09 | 2014-09-17 | 北京德众万全医药科技有限公司 | 一种含有去甲文拉法新的盐的药物组合物及其制备方法 |
EP2191822A1 (en) | 2008-11-26 | 2010-06-02 | LEK Pharmaceuticals d.d. | Controlled release pharmaceutical compositions comprising O-desmethyl-venlafaxine |
CZ200969A3 (cs) | 2009-02-06 | 2010-06-30 | Zentiva, K.S. | Nové soli desvenlafaxinu a zpusob jejich prípravy |
BR112012024576A2 (pt) | 2010-03-31 | 2016-05-31 | Wockhardt Ltd | composição farmacêutica de liberação modificada compreendendo desvenlafaxina ou sais da mesma e processo para preparação da dita composição |
CN102249936B (zh) * | 2010-05-19 | 2014-09-17 | 江苏豪森医药集团有限公司 | O-去甲基文拉法辛盐酸盐的水合物及其制备方法 |
RU2453559C1 (ru) * | 2010-10-11 | 2012-06-20 | Общество С Ограниченной Ответственностью "Ниармедик Плюс" | Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями |
WO2012140577A1 (en) | 2011-04-12 | 2012-10-18 | Lupin Limited | Modified release pharmaceutical compositions of desvenlafaxine |
US8481596B2 (en) | 2011-06-08 | 2013-07-09 | Lupin Limited | Polymomorph of desvenlafaxine benzoate |
CN102349879B (zh) * | 2011-10-14 | 2016-07-13 | 北京科信必成医药科技发展有限公司 | 一种去甲文拉法辛控释片及其制备方法 |
CA2922507C (en) * | 2013-08-26 | 2022-07-05 | Amorsa Therapeutics, Inc. | Single-layer oral dose of neuro-attenuating ketamine |
CN106187793A (zh) * | 2016-01-26 | 2016-12-07 | 赵鸣 | 5‑氨基酮戊酸及其衍生物的盐化合物和应用 |
TR201820634A2 (tr) | 2018-12-27 | 2020-07-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Desvenlafaksi̇ni̇n kati oral farmasöti̇k kompozi̇syonlari |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56324B1 (en) | 1982-12-13 | 1991-06-19 | American Home Prod | Phenethylamine derivatives and intermediates therefor |
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US6562629B1 (en) * | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
CA2368083A1 (en) | 1999-04-06 | 2000-10-12 | Sepracor Inc. | Derivatives of venlafaxine and methods of preparing and using the same |
IT1308475B1 (it) * | 1999-05-07 | 2001-12-17 | Gate Spa | Motoventilatore, particolarmente per uno scambiatore di calore di unautoveicolo |
WO2000076955A1 (en) | 1999-06-15 | 2000-12-21 | American Home Products Corporation | Enantiomers of o-desmethyl venlafaxine |
US6348494B1 (en) * | 2000-11-21 | 2002-02-19 | American Home Products Corporation | Ethers of o-desmethyl venlafaxine |
EP1355630B1 (en) * | 2000-08-15 | 2009-11-25 | The Board Of Trustees Of The University Of Illinois | Method of forming microparticles |
CA2436668C (en) * | 2001-02-12 | 2009-05-26 | Wyeth | Novel succinate salt of o-desmethyl-venlafaxine |
EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
-
2003
- 2003-06-09 BR BR0311693-0A patent/BR0311693A/pt not_active IP Right Cessation
- 2003-06-09 TW TW092115524A patent/TW200407108A/zh unknown
- 2003-06-09 WO PCT/US2003/018195 patent/WO2003103603A2/en active Application Filing
- 2003-06-09 NZ NZ537142A patent/NZ537142A/en unknown
- 2003-06-09 EP EP03757455A patent/EP1519720A4/en not_active Withdrawn
- 2003-06-09 AU AU2003247515A patent/AU2003247515A1/en not_active Abandoned
- 2003-06-09 CN CN038135493A patent/CN1658861A/zh active Pending
- 2003-06-09 KR KR10-2004-7019999A patent/KR20050013125A/ko not_active Application Discontinuation
- 2003-06-09 US US10/457,596 patent/US7001920B2/en not_active Expired - Fee Related
- 2003-06-09 JP JP2004510724A patent/JP4445853B2/ja not_active Expired - Fee Related
- 2003-06-09 MX MXPA04012347A patent/MXPA04012347A/es active IP Right Grant
- 2003-06-09 AR ARP030102045A patent/AR040177A1/es unknown
- 2003-06-09 RU RU2004139075/04A patent/RU2004139075A/ru not_active Application Discontinuation
- 2003-06-09 CA CA002488613A patent/CA2488613A1/en not_active Abandoned
- 2003-09-06 UA UAA200500166A patent/UA84271C2/ru unknown
-
2004
- 2004-11-22 NO NO20045065A patent/NO20045065L/no not_active Application Discontinuation
- 2004-11-24 CR CR7583A patent/CR7583A/es not_active Application Discontinuation
- 2004-12-06 IL IL16558404A patent/IL165584A0/xx unknown
- 2004-12-09 ZA ZA200409981A patent/ZA200409981B/xx unknown
- 2004-12-10 EC EC2004005491A patent/ECSP045491A/es unknown
-
2005
- 2005-10-21 US US11/256,241 patent/US7154001B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ZA200409981B (en) | 2010-05-26 |
US7154001B2 (en) | 2006-12-26 |
NZ537142A (en) | 2008-01-31 |
TW200407108A (en) | 2004-05-16 |
CN1658861A (zh) | 2005-08-24 |
WO2003103603A3 (en) | 2004-03-25 |
US20030236309A1 (en) | 2003-12-25 |
MXPA04012347A (es) | 2005-02-25 |
JP2005533772A (ja) | 2005-11-10 |
RU2004139075A (ru) | 2005-06-27 |
EP1519720A4 (en) | 2010-02-10 |
CR7583A (es) | 2008-08-21 |
EP1519720A2 (en) | 2005-04-06 |
US20060058552A1 (en) | 2006-03-16 |
WO2003103603A2 (en) | 2003-12-18 |
AU2003247515A1 (en) | 2003-12-22 |
BR0311693A (pt) | 2005-03-22 |
US7001920B2 (en) | 2006-02-21 |
JP4445853B2 (ja) | 2010-04-07 |
KR20050013125A (ko) | 2005-02-02 |
AR040177A1 (es) | 2005-03-16 |
ECSP045491A (es) | 2005-03-10 |
UA84271C2 (en) | 2008-10-10 |
IL165584A0 (en) | 2006-01-15 |
CA2488613A1 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045065L (no) | Nytt formatsalt av o-desmetyl-venlafaxin | |
CY1106952T1 (el) | Ηλεκτρικο αλας της ο-απομεθυλ-βενλαφαξινης | |
CY1108522T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
RS20050046A (en) | 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition | |
ES2196917T3 (es) | Amidas heteroaromaticas como inhibidores del factor xa`. | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
IL165262A (en) | Kinase inhibitors and pharmaceutical compositions containing them | |
AP1787A (en) | Novel perindopril salt and pharmaceutical compositions containing same. | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
CY1106471T1 (el) | Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης | |
NO20063308L (no) | Kombinasjon av flupirtin og tramadol | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
NO20044448L (no) | Nye forbindelser | |
CY1108238T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
AR038305A1 (es) | Composicion farmaceutica dispersable oralmente de perindopril | |
EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
EA200501925A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
ATE390128T1 (de) | Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit | |
ATE325115T1 (de) | Pyrimidinderivate als selektive cox-2-inhibitoren | |
EA200600455A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
EA200600456A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
EA200600454A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
SE0004827D0 (sv) | Therapeutic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |